Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma.
Schmitt AM, Gätje FB, Tran MYR, Midelashvili T, Xu X, Fleischer JR, Spahn H, Lai K, Tacke T, Younes S, Mittlmeier A, Schulze O, Hasanovic K, Blume ML, Rotter SM, Tesch TR, Schneider C, Todorovic J, Bohnenberger H, Kueffer S, Ströbel P, Papantonis A, Sax U, Agorku D, Rüberg S, Yassouri FE, Purushothaman R, Warratz S, Ferreira N, Schneider G, Igelmann S, Planque M, Fendt SM, Ghadimi M, Hessmann E, Ackermann L, De Oliveira T, Conradi LC.
Schmitt AM, et al.
Mol Cancer. 2026 Mar 27;25(1):112. doi: 10.1186/s12943-026-02628-3.
Mol Cancer. 2026.
PMID: 41896850
Free PMC article.